Cilloni D - Search Results

1

WT1 as a universal marker for minimal residual disease detection and quantification in myeloid leukemias and in myelodysplastic syndrome.

Cilloni D, Saglio G. Cilloni D, et al. Acta Haematol. 2004;112(1-2):79-84. doi: 10.1159/000077562. Acta Haematol. 2004. PMID: 15179007 Review.

2

Molecular events in chronic myeloid leukemia progression.

Guerrasio A, Serra A, Gottardi E, Cilloni D, Vischia F, Parvis G, Cilli V, Saglio G. Guerrasio A, et al. Among authors: cilloni d. Leukemia. 1997 Apr;11 Suppl 3:519-21. Leukemia. 1997. PMID: 9209443

3

Lack of SH3 domain does not imply a more severe clinical course in Ph+ chronic myeloid leukemia patients.

Tiribelli M, Tonso A, Ferrro D, Parzilae A, Cambrin GR, Scaravaglio P, Cilloni D, Gottardi E, Saglio G. Tiribelli M, et al. Among authors: cilloni d. Blood. 2000 Jun 15;95(12):4019-20. Blood. 2000. PMID: 10939800 Free article. No abstract available.

4

Novel type of BCR-ABL transcript in a chronic myelogenous leukaemia patient relapsed after bone marrow transplantation.

Roman J, Parziale A, Gottardi E, De Micheli D, Cilloni D, Tiribelli M, Gonzalez MG, del Carmen Rodriguez M, Torres A, Saglio G. Roman J, et al. Among authors: cilloni d. Br J Haematol. 2000 Nov;111(2):644-6. doi: 10.1046/j.1365-2141.2000.02394.x. Br J Haematol. 2000. PMID: 11122114 Free article.

5

Assessment of minimal residual disease (MRD) in CBFbeta/MYH11-positive acute myeloid leukemias by qualitative and quantitative RT-PCR amplification of fusion transcripts.

Guerrasio A, Pilatrino C, De Micheli D, Cilloni D, Serra A, Gottardi E, Parziale A, Marmont F, Diverio D, Divona M, Lo Coco F, Saglio G. Guerrasio A, et al. Among authors: cilloni d. Leukemia. 2002 Jun;16(6):1176-81. doi: 10.1038/sj.leu.2402478. Leukemia. 2002. PMID: 12040450

6

From genes to therapy: the case of Philadelphia chromosome-positive leukemias.

Cilloni D, Guerrasio A, Giugliano E, Scaravaglio P, Volpe G, Rege-Cambrin G, Saglio G. Cilloni D, et al. Ann N Y Acad Sci. 2002 Jun;963:306-12. doi: 10.1111/j.1749-6632.2002.tb04122.x. Ann N Y Acad Sci. 2002. PMID: 12095956

7

Quantitative assessment of WT1 expression by real time quantitative PCR may be a useful tool for monitoring minimal residual disease in acute leukemia patients.

Cilloni D, Gottardi E, De Micheli D, Serra A, Volpe G, Messa F, Rege-Cambrin G, Guerrasio A, Divona M, Lo Coco F, Saglio G. Cilloni D, et al. Leukemia. 2002 Oct;16(10):2115-21. doi: 10.1038/sj.leu.2402675. Leukemia. 2002. PMID: 12357365

8

Significant correlation between the degree of WT1 expression and the International Prognostic Scoring System Score in patients with myelodysplastic syndromes.

Cilloni D, Gottardi E, Messa F, Fava M, Scaravaglio P, Bertini M, Girotto M, Marinone C, Ferrero D, Gallamini A, Levis A, Saglio G; Piedmont Study Group on Myleodysplastic Syndromes. Cilloni D, et al. J Clin Oncol. 2003 May 15;21(10):1988-95. doi: 10.1200/JCO.2003.10.503. J Clin Oncol. 2003. PMID: 12743153

9

Usefulness of quantitative assessment of Wilms tumor suppressor gene expression in chronic myeloid leukemia patients undergoing imatinib therapy.

Cilloni D, Saglio G. Cilloni D, et al. Semin Hematol. 2003 Apr;40(2 Suppl 2):37-41. doi: 10.1053/shem.2003.50040. Semin Hematol. 2003. PMID: 12783374 Review.

10

Usefulness of quantitative assessment of the WT1 gene transcript as a marker for minimal residual disease detection.

Cilloni D, Gottardi E, Fava M, Messa F, Carturan S, Busca A, Guerrasio A, Saglio G. Cilloni D, et al. Blood. 2003 Jul 15;102(2):773-4; author reply 774. doi: 10.1182/blood-2003-03-0980. Blood. 2003. PMID: 12835231 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

210 results

Search Page

Filters